Literature DB >> 17426757

A novel strategy for identifying mutations that sensitize Drosophila eye development to caffeine and hydroxyurea.

E A Silva1, B J Lee, L S Caceres, D Renouf, B R Vilay, O Yu, J A Bradley, S D Campbell.   

Abstract

This report describes a novel strategy for isolating Drosophila mutants with conditional eye phenotypes that should be generally applicable for identifying genes required for cellular responses to specific drugs. To test the strategy, we screened 3 of the 5 major chromosome arms for hydroxyurea- and (or) caffeine-sensitive (huc) mutants, and isolated mutations affecting 5 different complementation groups. Most of these were represented by single alleles; however, we also isolated multiple alleles of huc(29DE) gene, an essential gene that is also associated with a nonconditional pupal lethal phenotype. We also identified huc(95E) mutants, which are extremely sensitive to caffeine. Although huc(95E) is a nonessential gene, mutant imaginal disc cells undergo caffeine-dependent apoptosis, and huc(95E) gene function is required for the viability of the organism when mutant larvae are exposed to levels of caffeine that controls can easily tolerate. We have mapped the cytological positions of huc(29D) and huc(95E) as a first step toward molecularly characterizing the relevant genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17426757     DOI: 10.1139/g06-098

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  2 in total

1.  RNA metabolism is the primary target of formamide in vivo.

Authors:  Rafael Hoyos-Manchado; Félix Reyes-Martín; Charalampos Rallis; Enrique Gamero-Estévez; Pablo Rodríguez-Gómez; Juan Quintero-Blanco; Jürg Bähler; Juan Jiménez; Víctor A Tallada
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

2.  The Smc5/Smc6/MAGE complex confers resistance to caffeine and genotoxic stress in Drosophila melanogaster.

Authors:  Xiao Li; Ran Zhuo; Stanley Tiong; Francesca Di Cara; Kirst King-Jones; Sarah C Hughes; Shelagh D Campbell; Rachel Wevrick
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.